All

Lecturio presents New Nephrology Course
22 October 2020

Lecturio presents New Nephrology Course

In the video lectures, Amy Sussman explains which patients are most at risk for renal disease, ways to prevent it, and how to diagnose it early.

Read more
Merger between Ateme and Anevia: signing of final agreements
7 October 2020

Merger between Ateme and Anevia: signing of final agreements

Following the announcement on July 31, 2020 of the entry into exclusive negotiations between ATEME and the main shareholders of Anevia and the completion, by these latest, of...

Read more
Izicap awarded “best Digital Loyalty Solution” by Juniper Research within their “Fintech & Payments Awards 2020”
2 October 2020

Izicap awarded “best Digital Loyalty Solution” by Juniper Research within their “Fintech & Payments Awards 2020”

This category recognises the most impactful & innovative financial products and services operating globally across numerous areas, including Retail & Payments, Banking, Fraud &...

Read more
TransferGo partners with Visa to bring global real-time transfers to users
21 October 2020

TransferGo partners with Visa to bring global real-time transfers to users

TransferGo, one of the world’s fastest growing money transfer companies, today partners with Visa, the world’s leader in digital payments, to bring real-time international...

Read more
Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies
7 October 2020

Federation Bio Launches with $50 Million Series A Financing and Expands Team to Pioneer Diverse Microbial Therapies

Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, today announced that it has closed a $50 million...

Read more
Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline
25 September 2020

Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline

Galecto., a privately-held biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced today the successful completion of a $64...

Read more
Enterome announces first patient dosed in Phase 2a trial of sibofimloc in Crohn’s disease
23 September 2020

Enterome announces first patient dosed in Phase 2a trial of sibofimloc in Crohn’s disease

ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, today...

Read more
Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases
22 September 2020

Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases

Siolta’s live biotherapeutic product (LBP) platform is designed to develop microbiome-based medicines and diagnostics for the prevention and treatment of chronic diseases in...

Read more
The Medical University of Pleven Leads the Digital Transformation of Medical Education in Bulgaria with Lecturio
17 September 2020

The Medical University of Pleven Leads the Digital Transformation of Medical Education in Bulgaria with Lecturio

Already an attractive destination for international and domestic medical students alike, the Medical University of Pleven now joins with Lecturio's help over 100 other medical...

Read more